Uses of Bispecific Antibody Coated Dendritic Cells Pulsed with Antigens and GM-CSF in Immune Regulation
GM-CSF administered before immunization exerted a sustained suppressive effect against the induction of myasthenia gravis (MG). This suppression was associated with lowered serum autoantibody levels, reduced T cell proliferative responses to AChR, and an expansion in the population of FoxP3+ regulatory T cells. Manipulating DCs to expand regulatory T cells is useful for the control of autoimmune diseases such as myasthenia gravis MG.
Patents:US 20,090,232,854 [
MORE INFO]
Inventor(s):
PRABHAKAR BELLUR S [US]; HOLTERMAN MARK J [US]; VASU CHENTHAMARAKSHAN [US]; MERIGGIOLI MATTHEW N [US]
Type of Offer:
Licensing
« More Biotech Patents